Introduction
Calculous disease of the biliary tract is common. Clinically, patients may present with symptoms or complications related to stones in the gallbladder or bile ducts. Cholesterol stones account for most stones encountered in patients in the Western hemisphere, whereas black and brown pigment stones are encountered frequently among patients in the Far East. 1 Ultrasonography is more than 95% effective for the diagnosis of cholelithiasis, but it is insensitive for the diagnosis of choledocholithiasis. 2 Therefore, common bile duct stones (CBDS) have traditionally been identified by direct contrast radiography through endoscopic, percutaneous or operative approaches.
In more than 90% of patients with choledocholithiasis, the process develops due to stone passage from the gallbladder into the extrahepatic biliary tract (secondary choledocholithiasis), 1 so management generally requires the removal of a gallbladder with CBDS. Choledocholithiasis is discovered in 8% to 20% of patients undergoing cholecystectomy, with most patients having clinical, biochemical or sonographic abnormalities suggestive of CBDS. [3] [4] [5] During the era of open cholecystectomy, preoperative indicators were frequently used to select patients for cholangiography. When selected, patients underwent intraoperative cholangiography (IOC),
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where CBDS may be identified and treated during the same operation.
Following the introduction of laparoscopic cholecystectomy (LC), several treatment options have emerged for the management of patients with gallbladder disease and suspected choledocholithiasis. The "one-step" approach involves LC, intraoperative diagnosis and laparoscopic management of CBDS. The "two-step" approach frequently relies on the preoperative diagnosis and treatment of CBDS prior to LC or, alternatively, CBDS are identified during LC and treated postoperatively by endoscopic sphincterotomy (ES). Although the "one-step" approach is an effective and safe option for many patients, 6,7 it has not gained wide acceptance among surgeons for various reasons. The debate regarding the optimal treatment approach for patients with CBDS is ongoing, unresolved, and beyond the scope of the current review.
As many surgeons continue to approach patients with gallbladder disease by attempting to identify and treat CBDS prior to LC, endoscopic retrograde cholangiography (ERC) has remained the most commonly applied technique for the preoperative detection of CBDS, and ES is commonly applied during ERC to facilitate CBDS removal. 3 Although ERC is effective for the diagnosis of choledocholithiasis, the procedure is invasive and has been reported to be associated with 
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s LIU AND ORGAN s complications in approximately 3% of all cases. 8 As some surgeons continue to apply traditional indicators to select patients for preoperative imaging by ERC, in some practices 30% to 70% of patients undergoing this procedure have no CBDS identified. 3 Concerns with the morbidity and costs associated with ERC have led to the development of alternative imaging methodologies for biliary tract evaluations. Table 1 lists the available biliary imaging modalities and  Table 2 3,9-42 lists the diagnostic efficacies, advantages and disadvantages of each. Magnetic resonance cholangiography (MRC) is one of the newer imaging tools that have emerged as potential diagnostic tools to replace ERC. 35, 43 This review summarizes the clinical experience with MRC and discusses its status in the management of patients with calculous disease of the biliary tract.
Techniques and limitations
MRC applies a heavily T2-weighted pulse sequence to delineate biliary tract anatomy and pathology. With this technique, the relatively static fluid within the biliary and pancreatic ducts appears as a white, rapidly flowing fluid, and background tissue appears hypodense; solid structures such as stones produce localized signal voids and appear black ( Figure  1 ). Either a single breath-hold technique or a non-breath-hold technique may be used for image acquisition. Some radio- 44 and the procedure may be completed in approximately 10 to 15 minutes without exposure to ionizing radiation or the application of sedatives or contrast material. Due to the small, enclosed space of the MR scanner, patients may be deemed unsuitable for this examination because of large body habitus or claustrophobia. Several patient fac- 
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tors have been shown to affect MRC accuracy; for example, the presence of ascites, periductal inflammation, periampullary duodenal diverticulum and crossing blood vessels may obscure the ductal fluid signal and lead to inadequate visualization of the distal CBD. 45 False-positive findings have been reported to occur as the result of a prominent sphincter of Oddi, duct tortuosity, cystic duct insertion, pneumobilia and surgical clips. 45 Additionally, radiographer inexperience contributes to inadequate application of image angles during image acquisition, resulting in the non-visualization of small CBDS. 45 Once obtained, the interpretation of MRC images by independent observers is consistent and reproducible. 12
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MRC accuracy
We are not aware of any randomized prospective studies published to date evaluating MRC accuracy and utility. However, between 1995 and 2002, numerous case control series were published comparing the diagnostic characteristics of MRC to standard imaging. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] Cumulatively, these investigations have reported MRC sensitivity of 90% (57-100%) and specificity of 
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s MAGNETIC RESONANCE CHOLANGIOGRAPHY s 96% (73-100%) for CBDS detection. Table 3 12-31 summarizes the findings from the major series. In these reports, the minimal resolution of MRC for CBDS was in the range of 2 to 3 mm. However, one group has reported decreased sensitivity of MRC in identifying CBDS of less than 6 mm in diameter. 21 Generally, the reported MRC accuracy for CBDS is comparable with the accuracies reported for ERC and IOC. MRC has been shown to possess superior diagnostic accuracy for visualization of intrahepatic stones when compared to ERC. 46 
Applications prior to LC
The concept of being able to rapidly and non-invasively image the biliary tract prior to LC is appealing to patients and physicians who may prefer to identify and treat CBDS prior to LC. Therefore, preoperative patients represent the most extensively investigated patient population to date. When applied in this setting, MRC accurately visualized CBDS in selected patients who were thought to benefit from preoperative endoscopic stone extraction. 15, 17, 27 Similarly, MRC identified patients without choledocholithiasis, eliminating unnecessary ERC in these individuals. These initial experiences have led some physicians to conclude that MRC is a valuable diagnostic tool in this patient population. [15] [16] [17] 27 While recognizing these advantages of MRC, most investigators agree that MRC is unnecessary and inappropriate in the management of patients for whom there is high suspicion of choledocholithiasis, such as those with cholangitis or severe jaundice. 17, 27, 31, 47 At the same time, some physicians believe that the liberal application of preoperative MRC in patients with low clinical suspicion for choledocholithiasis may contribute to delays and unnecessary expenses in patient management. 17 The initial results have prompted some physicians to question the value of MRC in patient management. 48 The cost effectiveness of various diagnostic options for patients with biliary pancreatitis was the focus of an investigation by Arguedas et al. 49 By applying a decision-tree analysis model, these investigators determined that ERC was the most cost-effective initial study when applied to patients with more than 58% probability of having CBDS, while observation and IOC were the most cost-effective strategies for patients with less than 15% probability of having choledocholithiasis. For patients with moderate probability of having CBDS (15-58%), either MRC or endoscopic ultrasonography was the most costeffective initial diagnostic strategy. 49 As data from mathematical modelling have indicated that patients with a moderate risk of having choledocholithiasis are the most appropriate patients to undergo initial imaging with MRC, there have been limited clinical data published to specifically guide patient selection for MRC prior to LC. In the study by Liu et al, patients were identified and triaged preoperatively into four categories based on the probability of choledocholithiasis. 47 Patients with high probability were directed to ERC/ES prior to LC. Moderate-probability patients were directed to MRC and subsequent ERC/ES when CBDS were visualized. Low-probability patients were directed 
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s LIU AND ORGAN s to LC with IOC, and very low-probability patients underwent LC without any imaging. These patient assignment criteria and the triage scheme are depicted in Table 4 and Figure 2 . Prospective application of this treatment algorithm resulted in finding choledocholithiasis in 92.6%, 32.4%, 3.8% and 0.9% of patients in the four groups, respectively. With this triage scheme, 95% of patients who underwent ERC had CBDS identified, and unexpected CBDS were found in 1.4% of all patients. MRC use was limited to 8.4% of the patients, representing a significant reduction from the 23.5% application in patients treated during the time period immediately prior to the study. Based on the findings from this study, it appears that stratification of CBDS risk improves resource utilization. However, additional research is needed to further improve patient management and define the roles of ERC and MRC in the perioperative setting.
Applications after LC
Considerations of bile leak, retained CBDS and bile duct injury are the usual indications leading to imaging of bile ducts in the postoperative setting. While there is less experience with MRC application in patients following LC, this approach possesses similar diagnostic accuracy for choledocholithiasis as in the preoperative setting. MRC accurately identifies and helps to characterize cystic duct leak, bile duct strictures and major bile duct injuries in the postoperative setting. [50] [51] [52] [53] The selection of an imaging modality in this setting should take into consideration the degree of suspicion for complications and the patient's intended treatment plan. When the clinical suspicion for complications is high and the problem is amenable to non-operative management, ERC or percutaneous transhepatic cholangiography should be considered initially to avoid unnecessary delays in therapy. MRC may be considered when patients with low to moderate suspicion of having biliary complications are encountered, where initial MRC imaging may prevent the use of unnecessary invasive procedures. Similarly, MRC may be useful for preoperative evaluation of selected patients with biliary tract injuries requiring operative reconstruction. Based on our review of published results, there are no available data to help identify patients who may benefit from MRC evaluation in this setting.
Evaluation of primary CBDS
Primary CBDS form de novo in the bile ducts and these are generally calcium bilirubinate stones. 1 The formation of primary CBDS is generally due to the combined effects of bacterial overgrowth and biliary stasis. Calcium bilirubinate stones 54 This high accuracy was achieved despite the mixed signal intensity found in 21% of stones in these patients. This group subsequently conducted a prospective evaluation of MRC accuracy for CBDS identification, in which MRC was found to possess sensitivity of 95% and specificity of 85% for CBDS identification when compared to ERC findings. 26 During this study, pneumobilia was recognized as a cause of false-positive results. These results suggest that MRC is accurate and may be useful for preoperative imaging in selected patients with primary CBDS.
The reported rate of recurrent CBDS following ERC ranges from 4% to 10%. [54] [55] [56] [57] Several risk factors for recurrence have been reported, including a CBD diameter of more than 20 mm, pneumobilia, and the presence of periampullary diverticulum. [54] [55] [56] [57] It has been suggested that regular surveillance ERCP is useful for early identification of recurrent CBDS and in preventing the development of cholangitis. 56, 57 Although the effectiveness of surveillance MRC has not been evaluated specifically, it would appear that this modality would be highly useful for long-term follow-up in these patients.
Summary
The diagnostic capabilities of MRC have undergone rigorous evaluations and these investigations have generally confirmed that MRC possesses diagnostic accuracies that are similar to those of direct cholangiography. MRC provides a safe, effective and non-invasive method to identify CBDS. The availability of MRC has made a dramatic impact on the management of patients with suspected choledocholithiasis in whom preoperative treatment of CBDS is contemplated. There is general agreement that MRC reduces and may eliminate the need for diagnostic ERC and it may reduce the occurrence of ERC-related morbidity. Clinical evidence suggests that MRC may be most beneficial and cost-effective when applied to patients with a moderate probability of having choledocholithiasis, but there are limited clinical data available to guide patient selection. Future investigations should be directed toward the development of safe and efficient MRC application strategies that are consistent with the goals and objectives of a minimally invasive approach to patient care.
